Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0FJYPL
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
MP-EV-20
|
|||||
| Synonyms |
MP-EV20; MP EV 20
Click to Show/Hide
|
|||||
| Organization |
MediaPharma Srl
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 5 Indication(s)
Breast cancer [ICD11:2C60-2C65]
Clinical candidate
Colorectal cancer [ICD11:2B91]
Clinical candidate
Lung cancer [ICD11:2C25]
Clinical candidate
Melanoma [ICD11:2C30]
Clinical candidate
Prostate cancer [ICD11:2C82]
Clinical candidate
|
|||||
| Antibody Name |
EV20
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-3 (ERBB3)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin F
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.